14-67143410-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_020806.5(GPHN):c.1797T>C(p.Asp599Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0042 in 1,610,834 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0031 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0043 ( 32 hom. )
Consequence
GPHN
NM_020806.5 synonymous
NM_020806.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.53
Publications
4 publications found
Genes affected
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
- sulfite oxidase deficiency due to molybdenum cofactor deficiency type CInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
- hereditary hyperekplexiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 14-67143410-T-C is Benign according to our data. Variant chr14-67143410-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 466203.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.53 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0031 (472/152276) while in subpopulation SAS AF = 0.00644 (31/4816). AF 95% confidence interval is 0.00486. There are 1 homozygotes in GnomAd4. There are 230 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 32 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00310 AC: 471AN: 152158Hom.: 1 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
471
AN:
152158
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00379 AC: 954AN: 251406 AF XY: 0.00431 show subpopulations
GnomAD2 exomes
AF:
AC:
954
AN:
251406
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00432 AC: 6298AN: 1458558Hom.: 32 Cov.: 27 AF XY: 0.00441 AC XY: 3203AN XY: 725794 show subpopulations
GnomAD4 exome
AF:
AC:
6298
AN:
1458558
Hom.:
Cov.:
27
AF XY:
AC XY:
3203
AN XY:
725794
show subpopulations
African (AFR)
AF:
AC:
22
AN:
33422
American (AMR)
AF:
AC:
58
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
AC:
41
AN:
26114
East Asian (EAS)
AF:
AC:
0
AN:
39678
South Asian (SAS)
AF:
AC:
861
AN:
86188
European-Finnish (FIN)
AF:
AC:
28
AN:
53408
Middle Eastern (MID)
AF:
AC:
10
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
5117
AN:
1108986
Other (OTH)
AF:
AC:
161
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
310
621
931
1242
1552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00310 AC: 472AN: 152276Hom.: 1 Cov.: 31 AF XY: 0.00309 AC XY: 230AN XY: 74464 show subpopulations
GnomAD4 genome
AF:
AC:
472
AN:
152276
Hom.:
Cov.:
31
AF XY:
AC XY:
230
AN XY:
74464
show subpopulations
African (AFR)
AF:
AC:
30
AN:
41570
American (AMR)
AF:
AC:
35
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
3466
East Asian (EAS)
AF:
AC:
1
AN:
5174
South Asian (SAS)
AF:
AC:
31
AN:
4816
European-Finnish (FIN)
AF:
AC:
4
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
361
AN:
68012
Other (OTH)
AF:
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
GPHN: BP4, BS2 -
Sep 24, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C;C4551954:Hyperekplexia 1 Benign:1
Dec 16, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.